Here are the 10-Q quarterly reports from BCB Bancorp Inc (BCBP) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BCBP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCBP filings page.
BCB Bancorp, Inc. (BCBP) reported a net loss of $132.453 million for the three months ended September 30, 2026, compared with net income of $4.262 million for the same period in 2025. Provision for credit losses on loans was $114.961 million, versus $4.080 million, while net interest income was $22.599 million, compared with $23.711 million.
For the nine months ended September 30, 2026, the company reported a net loss of $142.325 million. Net cash provided by operating activities was $19.739 million; net cash provided by investing activities was $314.803 million, including $163.617 million of proceeds from portfolio loan sales. Cash and equivalents were $500.313 million at September 30, 2026, compared with $276.584 million at December 31, 2025.
At September 30, 2026, loans receivable, net of allowance for credit losses, were $2,179.697 million, total deposits were $2,609.146 million, and stockholders’ equity was $246.082 million. Common shares outstanding were 30,751,822 as of November 2, 2026.
BCB Bancorp, Inc. reports weaker results for the quarter and six months ended June 30, 2026. Total assets were about $3.12 billion, down from $3.28 billion at December 31, 2025, while total deposits declined modestly to $2.64 billion.
For the June 2026 quarter, the company recorded a net loss of $14.8 million, compared with net income of $3.6 million a year earlier. Net interest income was relatively stable at $23.3 million, but results were heavily affected by a sharply higher provision for credit losses on loans of $19.0 million and a $5.3 million goodwill impairment. Non-interest income also included losses on loan sales and equity investments.
For the first six months of 2026, BCB reported a net loss of $9.9 million, versus a $4.8 million loss in 2025 and $8.7 million of net income in 2024. Operating cash flow remained positive at $14.7 million. The company reduced Federal Home Loan Bank advances from $235.0 million to $125.0 million, but stockholders’ equity declined to $291.9 million, partly reflecting losses and dividends.
BCB Bancorp, Inc. reported a return to profitability for the three months ended March 31, 2026, with net income of $4.9 million, compared with an $8.3 million loss a year earlier. Net income available to common shareholders was $4.4 million, or $0.26 per share, versus a loss of $0.51 per share in 2025.
Net interest income was $22.8 million, up slightly from $22.0 million, while the provision for credit losses on loans dropped sharply to $2.8 million from $20.8 million, driving the earnings swing. Total assets were $3.27 billion, loans receivable net were $2.66 billion, and deposits totaled $2.67 billion at March 31, 2026.
The allowance for credit losses on loans stood at $32.6 million, and non-accrual loans were $59.8 million, slightly lower than year-end 2025. The cannabis-related loan portfolio was $68.9 million, and stockholders’ equity was $307.4 million.
BCB Bancorp (BCBP) reported Q3 2025 results. Net income was $4.3 million, or $0.22 per diluted share, versus $6.7 million, or $0.36, a year ago. Net interest income was $23.7 million, with a $4.1 million provision for credit losses. For the nine months, the company posted a net loss of $0.5 million compared with $15.4 million in the prior year period, driven by higher credit loss provisions.
Total assets were $3.35 billion and loans, net of a $37.8 million allowance, were $2.79 billion, down from $3.00 billion at December 31, 2024. Deposits totaled $2.69 billion, down from $2.75 billion, while FHLB advances declined to $280.8 million from $455.4 million. Other real estate owned was $20.1 million following transfers from loans. Available-for-sale securities rose in fair value to $115.7 million as unrealized losses narrowed.
Preferred stock additional paid-in capital was $25.2 million. Shares outstanding were 17,228,206 as of November 1, 2025. The company highlighted a distinct cannabis-related loan segment of $69.1 million as of September 30, 2025, down from $103.2 million at year-end 2024.